Insider · CIK 0001887762
Bachleda Mark
Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA
Transactions
6
Companies
2
Filings
6
CIK
0001887762
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-10 | LYELLyell Immunopharma, Inc. · Option (right to buy)A Award | — |
| 2025-06-09 | LYELLyell Immunopharma, Inc. · Option (right to buy)A Award | — |
| 2023-03-16 | GRTXGalera Therapeutics, Inc.P Purchase | +$24.7K |
| 2023-02-25 | GRTXGalera Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-02-28 | GRTXGalera Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-10-08 | GRTXGalera Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
Recent filings
- 4Bachleda Mark0001887762-26-000002SEC(opens sec.gov)
- 4Bachleda Mark0001415889-25-016730SEC(opens sec.gov)
- 4Bachleda Mark0000899243-23-009095SEC(opens sec.gov)
- 4Bachleda Mark0000899243-23-006468SEC(opens sec.gov)
- 4Bachleda Mark0000899243-22-008580SEC(opens sec.gov)
- 4Bachleda Mark0000899243-21-039959SEC(opens sec.gov)
Companies
Address
C/O LYELL IMMUNOPHARMA, INC. 201 HASKINS WAY, SUITE 101
SOUTH SAN FRANCISCO, CA, 94080